GSTC - Expected US Company Earnings on Monday March 4th 2024

Crescent Energy Company Class A (CRGY) is expected to report $0.21 for Q4 2023

ThredUp Inc. (TDUP) is expected to report $-0.13 for Q4 2023

Wright Investors` Service Holdings Inc (IWSH) is expected to report for Q4 2023

Bridgford Foods Corporation (BRID) is expected to report for Q1 2024

Stitch Fix Inc. (SFIX) is expected to report $-0.21 for Q2 2024

Midwest Energy Emissions Corp (MEEC) is expected to report $-0.01 for Q4 2023

Akoya BioSciences Inc. (AKYA) is expected to report $-0.27 for Q4 2023

Eliem Therapeutics Inc (ELYM) is expected to report for quarter end 2023-12-31

Gamer Pakistan Inc. (GPAK) is expected to report for Q4 2023

Inhibitor Therapeutics Inc (INTI) is expected to report for Q4 2023

Global Ship Lease Inc New Class A (GSL) is expected to report $2.34 for Q4 2023

Greenpro Capital Corp. (GRNQ) is expected to report for Q4 2023

Vicarious Surgical Inc. Class A (RBOT) is expected to report $-0.12 for Q4 2023

SAB Biotherapeutics Inc. (SABS) is expected to report $-0.64 for Q4 2023

SUIC Worldwide Holdings Ltd (SUIC) is expected to report for Q4 2023

Grom Social Enterprises Inc. (GROM) is expected to report for Q4 2023

Saipem Spa (SAPMF) is expected to report for Q4 2023

Fresnillo Plc (FNLPF) is expected to report for Q4 2023

Boundary Gold & Copper Mng Ltd. (PRZFF) is expected to report for quarter end 2023-11-30

Community Bancorp Inc Vermont (CMTV) is expected to report for Q4 2023

Zalando SE ADR (ZLNDY) is expected to report for Q4 2023

Cross Timbers Royalty Trust (CRT) is expected to report for Q4 2023

Grupo Aval Acciones y Valores S.A. ADR (Each representing 20 preferred shares) (AVAL) is expected to report $0.05 for Q4 2023

Abacus Life Inc. (ABL) is expected to report for Q4 2023

Crawford & Company (CRD.B) is expected to report $0.2 for Q4 2023

Kolibri Global Energy Inc. (KGEI) is expected to report $0.12 for Q4 2023

TC Bancshares Inc. (TCBC) is expected to report for Q4 2023

Verde Clean Fuels Inc. (VGAS) is expected to report for Q4 2023

Capstone Green Energy Corporation (CGRNQ) is expected to report for quarter end 2023-12-31

Annexon Inc. (ANNX) is expected to report $-0.48 for Q4 2023

Spectral AI Inc. (MDAI) is expected to report for Q4 2023

Apogee Therapeutics Inc. (APGE) is expected to report $-0.45 for Q4 2023

Calavo Growers Inc. (CVGW) is expected to report for Q1 2024

Oramed Pharmaceuticals Inc. (ORMP) is expected to report $-0.12 for Q4 2023

Cara Therapeutics Inc. (CARA) is expected to report $-0.57 for Q4 2023

Coherus BioSciences Inc. (CHRS) is expected to report $-0.33 for Q4 2023

Sea Limited American Depositary Shares each representing one Class A (SE) is expected to report $-0.29 for Q4 2023

Sagimet Biosciences Inc. (SGMT) is expected to report $-0.62 for Q4 2023

Nxu Inc. (NXU) is expected to report for Q4 2023

Endo International plc (ENDPQ) is expected to report for quarter end 2023-12-31

vTv Therapeutics Inc. (VTVT) is expected to report for quarter end 2023-12-31

NanoVibronix Inc. (NAOV) is expected to report for Q4 2023

AeroVironment Inc. (AVAV) is expected to report $0.32 for Q3 2024

GitLab Inc. (GTLB) is expected to report $-0.19 for Q4 2024

Maris-Tech Ltd. (MTEK) is expected to report for quarter end 2023-12-31

Azul S.A. American Depositary Shares (each representing three preferred shares) (AZUL) is expected to report $-0.22 for Q4 2023

Conduit Pharmaceuticals Inc. (CDT) is expected to report for quarter end 2023-12-31

United Health Products Inc (UEEC) is expected to report for Q4 2023

OptimumBank Holdings Inc. (OPHC) is expected to report for quarter end 2023-12-31

ContextLogic Inc. (WISH) is expected to report for Q4 2023

Crawford & Company (CRD.A) is expected to report for quarter end 2023-12-31

Viant Technology Inc. (DSP) is expected to report $-0.2 for Q4 2023

Hongchang International Co Ltd Com (New) (HCIL) is expected to report for Q4 2023

Daseke Inc. (DSKE) is expected to report $-0.31 for Q4 2023

Perfect Corp. Class A (PERF) is expected to report $-0.01 for Q4 2023

Resonate Blends Inc (KOAN) is expected to report for Q4 2023

GlobeStar Therapeutics Corp (GSTC) is expected to report for quarter end 2023-12-31

Intensity Therapeutics Inc. (INTS) is expected to report for quarter end 2023-12-31

SEMrush Holdings Inc. Class A (SEMR) is expected to report $0.01 for Q4 2023

Rallybio Corporation (RLYB) is expected to report $-0.44 for Q4 2023

Silo Pharma Inc. (SILO) is expected to report for Q4 2023

UOL Group Limited ADR - Level I (UOLGY) is expected to report for quarter end 2023-12-31

Sohu.com Limited (SOHU) is expected to report $-0.41 for Q4 2023

Volcon Inc. (VLCN) is expected to report for Q4 2023

Shinhan Financial Group Co Ltd American Depositary Shares (SHG) is expected to report $0.67 for Q4 2023

Orchard Therapeutics plc (ORTX) is expected to report $-2.1 for Q4 2023

Science 37 Holdings Inc. (SNCE) is expected to report for Q4 2023

Drilling Tools International Corporation (DTI) is expected to report $0.15 for Q4 2023

GameSquare Holdings Inc. (GAME) is expected to report $-0.02 for Q4 2023

Cardio Diagnostics Holdings Inc. (CDIO) is expected to report $-0.13 for Q4 2023

Vivos Inc (RDGL) is expected to report for Q4 2023

GD Culture Group Limited (GDC) is expected to report for Q4 2023

Future FinTech Group Inc. (FTFT) is expected to report for Q4 2023

Gungnir Resources Inc (ASWRF) is expected to report for quarter end 2023-12-31

PHI Group Inc. (PHIL) is expected to report for Q2 2024

Nektar Therapeutics (NKTR) is expected to report $-0.2 for Q4 2023

Allakos Inc. (ALLK) is expected to report $-0.53 for Q4 2023

BioRestorative Therapies Inc (BRTX) is expected to report $-0.65 for Q4 2023

Ekso Bionics Holdings Inc. (EKSO) is expected to report $-0.11 for Q4 2023

Mesoblast Limited (MESO) is expected to report for Q2 2024

CISO Global, Inc (CISO) is expected to report for Q4 2023

Tenax Therapeutics Inc. (TENX) is expected to report $-8.15 for Q4 2023

LENSAR Inc. (LNSR) is expected to report for quarter end 2023-12-31

Kansas City Life Insurance Co (KCLI) is expected to report for quarter end 2023-12-31

Hepion Pharmaceuticals Inc. (HEPA) is expected to report $-2.63 for Q4 2023

BioStem Technologies Inc (BSEM) is expected to report $0.47 for Q4 2023

Li-Cycle Holdings Corp. (LICY) is expected to report $-0.13 for Q4 2023

Passage Bio Inc. (PASG) is expected to report $-0.41 for Q4 2023

RayzeBio Inc. (RYZB) is expected to report $-0.38 for Q4 2023

INNOVATE Corp. (VATE) is expected to report for quarter end 2023-12-31

Biloxi Marsh LDS Corp (BLMC) is expected to report for quarter end 2023-12-31

GBT Technologies Inc (GTCH) is expected to report for Q4 2023

Manuka Inc (MNKA) is expected to report for Q4 2023

Pasithea Therapeutics Corp. (KTTA) is expected to report for Q4 2023

La Rosa Holdings Corp. (LRHC) is expected to report for Q4 2023

Zivo Bioscience Inc. (ZIVO) is expected to report for Q4 2023

China Health Industries Holdings Inc (CHHE) is expected to report for Q2 2024

Orchestra BioMed Holdings Inc Com (OBIO) is expected to report $-0.4 for Q4 2023

Intuitive Machines Inc. (LUNR) is expected to report $-0.12 for Q4 2023

Paymentus Holdings Inc. Class A (PAY) is expected to report $0.05 for Q4 2023

Gaia Inc. (GAIA) is expected to report for quarter end 2023-12-31

Lendway Inc. (LDWY) is expected to report for quarter end 2023-12-31

Adaptimmune Therapeutics plc (ADAP) is expected to report $-0.12 for Q4 2023

Entrada Therapeutics Inc. (TRDA) is expected to report $-0.07 for Q4 2023

60 Degrees Pharmaceuticals Inc. (SXTP) is expected to report $-0.27 for Q4 2023

Knightscope Inc. (KSCP) is expected to report for Q4 2023

Stoke Therapeutics Inc. (STOK) is expected to report $-0.62 for Q4 2023

CervoMed Inc. (CRVO) is expected to report $-0.95 for Q4 2023

Royale Energy Funds Inc (ROYL) is expected to report for Q4 2023

International Stem Cell Corporation (ISCO) is expected to report for Q4 2023

Cyclacel Pharmaceuticals Inc. (CYCC) is expected to report $-6.35 for Q4 2023

hopTo Inc (HPTO) is expected to report for Q4 2023

ViewRay Inc. (VRAYQ) is expected to report for quarter end 2023-12-31

Cosan S.A. ADS (CSAN) is expected to report $0.18 for Q4 2023

Kaya Holdings (KAYS) is expected to report for Q4 2023

Eos Energy Enterprises Inc. (EOSE) is expected to report $-0.22 for Q4 2023

NuZee Inc. (NUZE) is expected to report for quarter end 2023-12-31

Precigen Inc. (PGEN) is expected to report $-0.08 for Q4 2023

Ocular Therapeutix Inc. (OCUL) is expected to report $-0.28 for Q4 2023

Monarch Cement Co. (MCEM) is expected to report for Q4 2023

Waitr Holdings Inc. (ASAP) is expected to report for Q4 2023

Allurion Technologies Inc. (ALUR) is expected to report $-0.51 for Q4 2023

Bitcoin Depot Inc Com (BTM) is expected to report $-0.08 for Q4 2023

Stellus Capital Investment Corporation (SCM) is expected to report $0.46 for Q4 2023

Intrusion Inc. (INTZ) is expected to report $-0.14 for Q4 2023

Northwest Pipe Company (NWPX) is expected to report $0.42 for Q4 2023

Webco Industries Inc. (WEBC) is expected to report for Q2 2024

Guided Therapeutics Inc (GTHP) is expected to report for Q4 2023

Modiv Industrial Inc. Class C (MDV) is expected to report $0.38 for Q4 2023

WVS Financial Corp. (WVFC) is expected to report for Q2 2024

Schaeffler AG Bearer Preference Shares (SCFLF) is expected to report for Q4 2023

NCS Multistage Holdings Inc. (NCSM) is expected to report for Q4 2023

Advantage Energy Ltd (AAVVF) is expected to report for Q4 2023

Hugoton Royalty Trust (HGTXU) is expected to report for Q4 2023

Tenaga Nasional Bhd ADR (TNABY) is expected to report for quarter end 2023-12-31

SRM Entertainment Inc. (SRM) is expected to report for Q4 2023